SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $68.00 $261.00 | 8 | |
Mycophenolic acid, a reversible inhibitor of IMPDH, suppresses de novo guanosine nucleotide synthesis by binding to the enzyme's NAD+ site, thereby reducing lymphocyte proliferation and immune response. | ||||||
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $36.00 $107.00 | 1 | |
MMF is an IMPDH1 blocker and is under research for its potential in immunosuppression to reduce the likelihood of organ transplant rejection. Additionally, studies have shown it having therapeutic properties in addressing autoimmune conditions, including lupus nephritis and rheumatoid arthritis. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $62.00 $108.00 $210.00 | 1 | |
Ribavirin indirectly inhibits IMPDH1 by resembling its natural substrate, leading to faulty RNA synthesis and viral replication inhibition, which indirectly reduces IMPDH1's action in proliferative processes. | ||||||
Mizoribine | 50924-49-7 | sc-359617 sc-359617A | 10 mg 25 mg | $107.00 $224.00 | ||
Mizoribine inhibits IMPDH by competing with inosine monophosphate for the active site, reducing guanine nucleotide synthesis, which is crucial for DNA and RNA synthesis in proliferating cells. | ||||||
Tiazofurin | 60084-10-8 | sc-475805 | 5 mg | $440.00 | ||
Tiazofurin is metabolized into an active form that inhibits IMPDH, leading to decreased levels of guanosine nucleotides, thus affecting cell proliferation and differentiation. | ||||||
Benzamide | 55-21-0 | sc-202494 sc-202494A | 5 g 25 g | $19.00 $31.00 | 1 | |
Benzamide inhibits IMPDH, leading to reduced guanosine nucleotide synthesis, which is critical for DNA and RNA synthesis, thus affecting cell growth and proliferation. | ||||||
Leflunomide | 75706-12-6 | sc-202209 sc-202209A | 10 mg 50 mg | $20.00 $81.00 | 5 | |
Leflunomide metabolite inhibits dihydroorotate dehydrogenase, indirectly reducing GTP pools necessary for T-cell activation and proliferation, thereby indirectly influencing IMPDH1 activity. | ||||||